시장보고서
상품코드
1684440

세계의 상처 치료용 생물제제 시장 : 제품별, 창상 유형별, 최종사용자별, 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 점유율 및 예측(2025-2032년)

Wound Care Biologics Market, By Product, By Wound Type, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 379 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

상처 치료용 생물제제 시장 규모는 2024년 22억 4,565만 달러로 평가되었고, 2025-2032년 연평균 복합 성장률(CAGR)은 5.5%를 보일 전망입니다.

상처 치료용 생물제제 시장 역학

욕창의 유병률 증가와 생물학적 제제 기반 상처 치료에 대한 인식이 높아지면서 시장 수요를 촉진할 것으로 예상됩니다.

상처 치료용 생물제제 시장은 만성 상처의 유병률 증가, 생명공학 기술의 발전, 생물학적 제제를 통한 상처 치료에 대한 인식 등 다양한 요인으로 인해 크게 성장하고 있습니다. 욕창과 정맥성 하지 궤양의 발생이 증가함에 따라 생체 공학적으로 설계된 대체 피부 및 양막 조직 제품과 같은 보다 효과적인 치료 옵션이 필요하며, 이는 시장 성장을 가속하고 있습니다. 전 세계 당뇨병 환자 증가로 인해 당뇨병성 족부 궤양이 증가하고 있으며, 생물학적 제제와 같은 첨단 상처 치유 솔루션이 요구되고 있습니다. 국제당뇨병연맹(IDF)에 따르면 전 세계적으로 약 5억 3,700만 명의 성인이 당뇨병을 앓고 있으며, 이 숫자는 앞으로도 계속 증가할 것으로 예상되어 첨단 상처치료에 대한 수요가 증가하고 있습니다.

바이오기술의 급속한 발전으로 치유를 촉진하고 합병증을 감소시키는 차세대 상처 치료용 생물제제가 개발되고 있습니다. 고령자는 욕창, 조직 재생 등의 위험이 높아 만성 상처에 걸리기 쉬우며, 고령화는 시장 성장의 주요 요인입니다. 정부와 민간 기업들은 보다 효과적이고 합리적인 가격의 상처 치료용 생물제제를 개발하기 위해 생명공학 연구에 투자하고 있습니다. 미국을 포함한 많은 국가에서 메디케어 및 메디케이드 프로그램에 따라 첨단 상처 치료 제품에 대한 상환이 이루어지고 있으며, 이는 생물학적 제제의 접근성을 높이고 있습니다.

상처 치료용 생물제제 시장 : 주요 고려사항

리서치 애널리스트의 분석에 따르면, 세계 시장은 예측 기간(2025-2032년) 동안 연평균 약 5.5%의 연평균 복합 성장률(CAGR)로 매년 성장할 것으로 예상됩니다.

제품별로는 생물학적 피부 대체재 부문이 노인들의 상처 치유에 대한 높은 수요로 인해 2024년 가장 높은 시장 점유율을 보였습니다.

상처 유형별로는 욕창, 당뇨성 족부궤양 등의 높은 유병률로 인해 궤양 분야가 2024년 주요 상처 유형 분야로 부상했습니다.

최종 사용자별로 보면, 2024년 병원 부문은 상처 치료 및 수술 치료 등 수요가 높아 주요 최종 사용자로 부상했습니다.

지역별로는 북미가 2024년 당뇨병 진단에 있어 첨단 의료 솔루션의 존재로 인해 북미가 주요 수익원이 되었습니다.

상처 치료용 생물제제 시장 : 세분화 분석

상처 치료용 생물제제 세계 시장은 제품, 상처 유형, 최종 사용자, 지역에 따라 세분화됩니다.

제품은 생물학적 피부 대체제와 국소제로 크게 두 가지로 나뉩니다. 생물학적 피부 대체물 부문이 시장을 주도하고 있습니다. 전통적인 치료법에서 생물학적 제제 및 생체공학 조직으로 전환하는 추세는 이 부문 수요를 촉진하고 있습니다.

시장은 상처의 유형에 따라 궤양, 수술 상처 및 외상성 상처, 화상의 세 가지로 분류됩니다. 궤양 분야는 노년층의 높은 욕창 유병률이 이 분야의 성장에 기여하고 있어 가장 큰 점유율을 차지할 것으로 예상됩니다.

시장은 최종 사용자별로 병원, 외래수술센터(ASC), 기타 세 가지로 분류됩니다. 최종 사용자별로는 병원이 가장 높은 점유율을 차지하고 있습니다. 당뇨병, 수술, 화상 치료에 대한 수요 증가가 시장 성장을 보완하고 있습니다.

상처 치료용 생물제제 시장 : 지역별 분석

상처 치료용 생물제제 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카에 분포되어 있습니다. 북미는 상처 치료용 생물제제 시장에서 큰 점유율을 차지하고 있으며, 그 주된 이유는 고도의 의료 인프라와 만성 상처의 높은 유병률에 기인합니다. 이 지역은 고령화 및 당뇨병 유병률 증가로 인해 고급 상처 치료 솔루션에 대한 수요가 증가하고 있습니다. 아시아태평양은 상처 치료용 생물제제 시장에서 가장 빠르게 성장할 것으로 예상됩니다. 환자 인구 증가, 당뇨병과 같은 만성 질환의 유병률 증가, 의료 인프라 개선 등의 요인이 시장 성장을 견인하고 있습니다. 라틴아메리카는 상처 치료용 생물제제의 성장 기회를 제공하고 있으며, 브라질과 멕시코가 시장을 주도하고 있습니다.

상처 치료용 생물제제 시장 : 경쟁 구도

상처 치료용 생물제제 시장은 치열한 경쟁이 특징이며, 주요 기업들은 혁신적인 제품 출시와 시장 확대를 위한 연구개발에 집중하고 있습니다. 시장 진출기업들은 성장하는 세계 상처 치료 시장에 대응하기 위해 제품 라인 강화에 주력하고 있습니다. 바이오테크놀러지의 끊임없는 기술 혁신으로 보다 효과적인 상처 치료용 생물제제가 개발되어 치료 성적이 향상되고 있습니다. 각 업체들은 제품 포트폴리오를 확장하고 시장에서의 입지를 강화하기 위해 제휴, 합병, 인수합병에 힘쓰고 있습니다.

목차

제1장 상처 치료용 생물제제 시장 개요

  • 조사 범위
  • 시장 추정 기간

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 상처 치료용 생물제제 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장 향후 동향

제4장 상처 치료용 생물제제 시장 : 산업 분석

  • PEST 분석
  • Porter의 Five Forces 분석
  • 시장 성장 전망 : 맵핑
  • 규제 체제 분석

제5장 상처 치료용 생물제제 시장 : 높아지는 지정학적 긴장의 영향

  • COVID-19 팬데믹의 영향
  • 러시아-우크라이나 전쟁의 영향
  • 중동 분쟁의 영향

제6장 상처 치료용 생물제제 시장 구도

  • 상처 치료용 생물제제 시장 점유율 분석(2024년)
  • 주요 제조업체별 분석 데이터
    • 기존 기업 분석
    • 신규 기업 분석

제7장 상처 치료용 생물제제 시장 : 제품별

  • 개요
    • 부문별 점유율 분석 : 제품별
    • 제품별 부문 점유율 분석
    • 생물학적 피부 대체품
    • 외용제

제8장 상처 치료용 생물제제 시장 : 창상 유형별

  • 개요
    • 부문별 점유율 분석 : 창상 유형별
    • 궤양
    • 수술창 및 외상성 창상
    • 화상

제9장 상처 치료용 생물제제 시장 : 최종사용자별

  • 개요
    • 부문별 점유율 분석 : 최종사용자별
    • 병원
    • 외래수술센터(ASC)
    • 기타

제10장 상처 치료용 생물제제 시장 : 지역별

  • 서론
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인
    • 네덜란드
    • 스웨덴
    • 러시아
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 주요 제조업체
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주
    • 인도네시아
    • 태국
    • 필리핀
    • 기타
  • 라틴아메리카(LATAM)
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카(MEA)
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제11장 주요 벤더 분석 : 상처 치료용 생물제제 업계

  • 경쟁 대시보드
    • 경쟁 벤치마킹
    • 경쟁 포지셔닝
  • 기업 개요
    • Smith &Nephew
    • Molnlycke Health Care
    • ConvaTec Group
    • Coloplast
    • 3M Health Care
    • Organogenesis Holdings
    • Integra LifeSciences
    • MiMedx Group
    • PolyNovo
    • Derma Sciences
    • Medline Industries
    • Hollister Incorporated
    • Aroa Biosurgery
    • Kerecis
    • Cresilon
    • Others

제12장 AnalystView의 전방위적 분석

LSH 25.04.15

REPORT HIGHLIGHT

Wound Care Biologics Market size was valued at USD 2,245.65 Million in 2024, expanding to a CAGR of 5.5% from 2025 to 2032.

Wound Care Biologics are advanced medical products derived from natural, biological sources that help facilitate wound healing. They are typically used in treating chronic wounds, burns, ulcers, and surgical wounds that are difficult to heal with conventional treatments.

Wound Care Biologics Market- Market Dynamics

Increasing prevalence of pressure ulcers and awareness about biologics based wound therapies are expected to propel market demand

The Wound Care Biologics Market is experiencing significant growth, driven by various factors, including the rising prevalence of chronic wounds, advancements in biotechnology and awareness about biologics therapies. The occurrence of pressure ulcers and venous leg ulcers has increased, necessitating more effective treatment options like bioengineered skin substitutes and amniotic tissue products which is also boosting market growth. The global increase in diabetes cases has led to a rise in diabetic foot ulcers, which require advanced wound healing solutions like biologics. According to the International Diabetes Federation (IDF), approximately 537 million adults worldwide have diabetes, and this number is expected to rise, leading to a higher demand for advanced wound care.

The rapid progress in biotechnology has led to the development of next-generation wound care biologics that accelerate healing and reduce complications. The aging population is a key contributor to market growth, as elderly individuals are more prone to chronic wounds due to high risks of pressure ulcers, tissue regeneration, etc. Governments and private entities are investing in biotechnology research to develop more effective and affordable wound care biologics. Many countries, including the U.S., provide reimbursement for advanced wound care products under Medicare and Medicaid programs, making biologics more accessible.

Wound Care Biologics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.5% over the forecast period (2025-2032)

Based on Product segmentation, the biological skin substitutes segment was predicted to show maximum market share in the year 2024, due to high demand from older aged adults for wound healing.

Based on Wound Type segmentation, the ulcers segment was the leading Wound Type segment in 2024, owing to the high prevalence of pressure ulcers and diabetic foot ulcers, etc.

Based on End User segmentation, the hospital segment was the leading End User segment in 2024, owing to the high need for wound care, surgical care, etc.

Based on the region, North America was the leading revenue generator in 2024, owing to the presence of advanced healthcare solutions in diabetic diagnosis.

Wound Care Biologics Market- Segmentation Analysis:

The Global Wound Care Biologics Market is segmented based on Product, Wound Type, End User, and Region.

The market is divided into two categories based on Product: biological skin substitutes and topical agents. The biological skin substitutes segment dominates the market. The growing shift from traditional treatment to biologics, bioengineered tissues is fueling segment demand.

The market is divided into three categories based on the Wound Type: ulcers, surgical & traumatic wounds, and burns. The ulcers segment is expected to hold the largest share due to the high prevalence of pressure ulcers among older adults is contributing to segment growth.

The market is divided into three categories based on End Users: hospitals, ambulatory surgical centers, and others. The hospitals segment holds the highest share of the End User segment. The growing demand for treatment of diabetes, surgeries & burns is supplementing market growth.

Wound Care Biologics Market- Geographical Insights

Across the world, the Wound Care Biologics market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America holds a significant share of the wound care biologics market, primarily due to its advanced healthcare infrastructure and high prevalence of chronic wounds. The region's aging population and increasing incidence of diabetes contribute to the demand for advanced wound care solutions. The Asia-Pacific region is anticipated to exhibit the fastest growth in the wound care biologics market. Factors such as a large patient population, increasing prevalence of chronic diseases like diabetes, and improving healthcare infrastructure drive market growth. Latin America offers growth opportunities in wound care biologics, with Brazil and Mexico leading the market.

Wound Care Biologics Market- Competitive Landscape:

The wound care biologics market is characterized by intense competition, with key players focusing on research and development to introduce innovative products and expand their market reach. Market players focusing on enhancing product lines to address the growing global wound care market. Continuous innovations in biotechnology have led to more effective wound care biologics, enhancing treatment outcomes. Companies engage in partnerships, mergers, and acquisitions to expand product portfolios and strengthen market presence.

Recent Developments:

In 2024, Cresilon developed Traumagel and algae derived gel which got FDA approval in August 2024.

In 2024, PolyNovo announced its plan to expand its manufacturing capabilities and enhance its product portfolio.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL WOUND CARE BIOLOGICS MARKET KEY PLAYERS

  • Smith & Nephew
  • Molnlycke Health Care
  • ConvaTec Group
  • Coloplast
  • 3M Health Care
  • Organogenesis Holdings
  • Integra LifeSciences
  • MiMedx Group
  • PolyNovo
  • Derma Sciences
  • Medline Industries
  • Hollister Incorporated
  • Aroa Biosurgery
  • Kerecis
  • Cresilon
  • Others

GLOBAL WOUND CARE BIOLOGICS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019-2032

  • Biological Skin Substitutes
  • Topical Agents

GLOBAL WOUND CARE BIOLOGICS MARKET, BY WOUND TYPE- MARKET ANALYSIS, 2019-2032

  • Ulcers
  • Surgical & Traumatic Wounds
  • Burns

GLOBAL WOUND CARE BIOLOGICS MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Hospitals
  • Ambulatory Surgical Centers
  • Others
  • GLOBAL WOUND CARE BIOLOGICS MARKET BY REGION- MARKET ANALYSIS, 2019-2032
  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Wound Care Biologics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Wound Care Biologics Market Snippet by Product
    • 2.1.2. Wound Care Biologics Market Snippet by Wound Type
    • 2.1.3. Wound Care Biologics Market Snippet by End User
    • 2.1.4. Wound Care Biologics Market Snippet by Country
    • 2.1.5. Wound Care Biologics Market Snippet by Region
  • 2.2. Competitive Insights

3. Wound Care Biologics Key Market Trends

  • 3.1. Wound Care Biologics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Wound Care Biologics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Wound Care Biologics Market Opportunities
  • 3.4. Wound Care Biologics Market Future Trends

4. Wound Care Biologics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Wound Care Biologics Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Wound Care Biologics Market Landscape

  • 6.1. Wound Care Biologics Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Wound Care Biologics Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. Biological Skin Substitutes
    • 7.1.3. Topical Agents

8. Wound Care Biologics Market - By Wound Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Wound Type, 2024 & 2032 (%)
    • 8.1.2. Ulcers
    • 8.1.3. Surgical & Traumatic Wounds
    • 8.1.4. Burns

9. Wound Care Biologics Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Ambulatory Surgical Centers
    • 9.1.4. Others

10. Wound Care Biologics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Wound Care Biologics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Wound Care Biologics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Wound Care Biologics Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Wound Care Biologics Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Wound Care Biologics Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Wound Care Biologics Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Smith & Nephew
    • 11.2.2. Molnlycke Health Care
    • 11.2.3. ConvaTec Group
    • 11.2.4. Coloplast
    • 11.2.5. 3M Health Care
    • 11.2.6. Organogenesis Holdings
    • 11.2.7. Integra LifeSciences
    • 11.2.8. MiMedx Group
    • 11.2.9. PolyNovo
    • 11.2.10. Derma Sciences
    • 11.2.11. Medline Industries
    • 11.2.12. Hollister Incorporated
    • 11.2.13. Aroa Biosurgery
    • 11.2.14. Kerecis
    • 11.2.15. Cresilon
    • 11.2.16. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제